Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 404-740-9 | CAS number: 115895-09-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral (OECD 401), rat: LD50 > 5000 mg/kg bw (limit test)
Dermal (OECD 402), rat: LD50 > 2000 mg/kg bw (limit test)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from November 28th, 1988 to December 12th, 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study performed according to OECD Guidelines for testing of chemicals (no 401)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Wistar outbred (Bor:WISW)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test animals
Mult, about 16 weeks old, albino rats were used. They ware Wistar outbred
rats (Bor:WISW) obtained from a colony, maintained under SPF—conditions at
the Breeding Centre for Laboratory Animals, F. Winkelmann GmbH, Borchen,
F.R. Gerinany. The body weights of the males varied from 308 to 354 g, those
of the females from 182 to 202 g. The animals ware kept under the
environmental conditions of the Institute’s animal house for about 13 weeks
prior to the test.
Housing and maintenance
The rats ware housed in groups of f ive, males and females separated, in
stainless steel cages with wire—screen bottom and front, in a room
ventilated with about 10 air changes per hour and maintained at 20—24°C.
Relative humidity was regulated between 40 and 70 per cent, lighting was
artificial by fluorescent tubes, time switch—controlled at a sequence of
12 hours light, 12 hours dark. Tap water was freely available at all times
by means of an automatic watering system. The rats had free access to the
Institute’s cereal—based, open—formula diet for rats and mice,
except in the overnight period before dosing tili 4 hours after dosing,
when food was withheld. The diet is analyzed regularly for nutrients and
contaminants. Tap water is analyzed regularly for
contaminants. - Route of administration:
- oral: gavage
- Vehicle:
- maize oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25%
- Amount of vehicle (if gavage): 20 mL/kg bw
- Justification for choice of vehicle: maize oil was selected as it was shown to be an appropriate vehicle in a pre-test study
MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bw - Doses:
- one single dose of 20.0 ml per kg body weight
This dose level is equal to 5000mg test substance per kg body weight - No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Preliminary study:
- A preliminary study was carried out to find an appropriate vehicle and the
general level of acute toxicity of the test substance.
After these preliminary observations, the substance was given by gavage as
a 25% (w/v) suspension in maize oil, in one single dose of 20.0 ml per kg
body to 5 males and 5 females. This dose level is equal to 5000 mg test
substance per kg body weight. 1f a dose level of 5000 mg/kg or more does
not cause compound—related mortality, then a full study with various dose
levels is not required (OECD—Guidelines for Testing of Chemicals).
The rats were observed frequently for signs of intoxication, during the
first 4 hours after treatment and thereafter, at least once daily
throughout an observation period of 14 days. The individual body weights of
the rats were recorded on day 0, 3, 7 and 14. At the end of the observation
period, the rats were killed and examined grossly. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured and all rats looked quite heathly throughout the remaining part of the 14-day observation period
- Clinical signs:
- other: Except signs of sluggishness and piloerection during the first few hours after treatment no signs of intoxication were observed
- Gross pathology:
- Macroscopic examination of the rats at the termination of the study
revealed a mottled surface of one of the kidneys in one male and one
female. No other treatment—related gross alterations were found.
At necropsy, 1/5 males and 1/5 females had a mottled surface of one kidney, which is not considered to be substance-related. No other gross abnormalities were observed. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- From the mortality figures, the oral LD50 of “AF—366” was found to exceed
5000 mg per kg body weight, both for male and for female rats. Therefore,
the test substance can be classified as unharmful (EC—directive 83/467/EEC,
Official Journal of the European Communities, L 257, September 16, 1983).
Not classified.
Reference
Table 1: Mortality and clinical signs
Dose |
Toxicological results* |
Duration of clinical signs |
Time of death |
Mortality (%) |
Males |
||||
5000 |
0/5/5 |
1-24 h |
- |
0 |
Females |
||||
5000 |
0/5/5 |
1-24 h |
- |
0 |
Overall LD50 > 5000 mg/kg bw |
* first number = number of dead animals
second number = number of animals with systemic clinical signs
third number = number of animals used
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study, and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 Nov-14 Dec 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with acceptable restrictions. The test substance (a solid) was applied under occlusive conditions.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- adopted in February 1987
- Deviations:
- yes
- Remarks:
- exposure under occlusive conditions
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Wistar outbred (Bor:WISW)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Breeding Centre for Laboratory Animals, F. Winkelmann GmbH, Borchen, Germany
- Age at study initiation: approximately 19 weeks
- Weight at study initiation: 310-360 g (males), 190-230 g (females)
- Housing: before dosing, the rats were housed in groups of five per sex, in stainless steel cages with a wire-screen bottom and front. After dosing, the rats were housed individually in stainless steel cages with a wire-screen bottom and front.
- Diet: CIVO cereal-based, open-formula diet for rats, ad libitum
- Water: tap water, ad libitum
- Acclimation period: approximately 14 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-24
- Humidity (%): 40-60
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 30 Nov 1988 To: 14 Dec 1988 - Type of coverage:
- occlusive
- Vehicle:
- maize oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: the dorsal and ventral clipped area of the trunk of the animals
- Type of wrap if used: the test material was held in contact with the skin with a plastic film, which was secured by an elastic adhesive bandage (Tensoplast) around the trunk of the rat
REMOVAL OF TEST SUBSTANCE
- Washing (if done): the residual test material was cleaned from the treated area with water
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 8 mL/kg bw
- For solids, paste formed: no, a suspension was prepared
VEHICLE
- Amount(s) applied (volume or weight with unit): 8 mL/kg bw
- Concentration (if solution): 75% - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations of clinical signs were made several times on Day 0 (post-administration) until 4 hours after dosing and daily thereafter; weighing was performed on Day 0 (pre-administration), 3, 7 and 14; skin irritation effects were assessed on Day 1, 3 and 7
- Necropsy of survivors performed: yes, all gross pathological changes were recorded
- Other examinations performed: clinical signs, mortality, skin irritation - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There was no mortality during the 14-day study period (see Table 1).
- Clinical signs:
- other: 5/5 males and 5/5 females were moderately sluggish from 1 up to 4 hours after administration of the test substance. Piloerection was observed at the 24-hour reading time point only, in 5/5 males and 5/5 females (see Table 1).
- Gross pathology:
- No treatment-related effects were observed during the gross pathological examination.
- Other findings:
- - Other observations: there were no skin irritation effects following exposure to the test substance
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
DSD: not classified
Reference
Table 1: Mortality and clinical signs
Dose |
Toxicological results* |
Duration of clinical signs |
Time of death |
Mortality (%) |
Males |
||||
2000 |
0/5/5 |
1-24 h |
- |
0 |
Females |
||||
2000 |
0/5/5 |
1-24 h |
- |
0 |
Overall LD50 > 2000 mg/kg bw |
* first number = number of dead animals
second number = number of animals with systemic clinical signs
third number = number of animals used
Table 2: Individual and mean body weight changes
Body weight (g) |
||||
|
Day 0 |
Day 3 |
Day 7 |
Day 14 |
Males |
||||
1 |
344 |
333 |
346 |
354 |
2 |
310 |
304 |
320 |
328 |
3 |
350 |
342 |
363 |
375 |
4 |
358 |
352 |
354 |
354 |
5 |
360 |
360 |
361 |
372 |
Mean body weight, males (g) |
344 |
338 |
349 |
357 |
|
||||
6 |
228 |
223 |
223 |
220 |
7 |
190 |
180 |
190 |
180 |
8 |
230 |
221 |
204 |
221 |
9 |
203 |
200 |
208 |
201 |
10 |
196 |
193 |
193 |
196 |
Mean body weight, females (g) |
209 |
203 |
204 |
204 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study, and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC)No 1907/2006
Additional information
The acute toxicity of ethyl 3,5-dichloro-4- hexadecyloxycarbonyloxybenzoate (AF-366) was assessed in an oral toxicity study and a dermal toxicity study.
In an acute oral toxicity study performed according to OECD guideline 401, the limit dose of 5000 mg/kg of the test substance was administered to 5 rats/sex by gavage (Spanjers, 1988a). No mortality was observed, and there were no effects on body weight during the 14-day observation period. The necropsy and gross pathological examination did not reveal any treatment-related effects. Therefore, the LD50 is > 5000 mg/kg bw for male and female rats.
The acute dermal toxicity of ethyl 3,5 -dichloro-4 -hexadecyloxycarbonyloxybenzoate was assessed in a limit test that was performed according to OECD 402 (Spanjers, 1998b). A single dose of 2000 mg/kg bw of the test substance was applied as a 25% solution in maize oil to the shaved skin of rats under occlusive conditions and left for 24 hours. There was no mortality during the 14-day observation period. The mean body weight of the females was reduced from day 3 until sacrifice on day 14. The necropsy and gross pathological examination did not show any treatment-related effects. Therefore, the LD50 (dermal) is > 2000 mg/kg bw for male and female rats.
Justification for classification or non-classification
The available data on acute toxicity of the test substance does not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and is therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.